Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allasma
- Development stage
- Unknown
- Lead developer
- Wilson Drugs & Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Allasma is an Ayurvedic herbo-mineral proprietary medicine developed and manufactured by Wilson Drugs & Pharmaceuticals. Formulated as an oral tablet, it is primarily used as an antipyretic and anti-inflammatory treatment for fevers of various origins, including low-grade, high-grade, and chronic fevers. It is also indicated for the relief of symptoms associated with flu, cough, throat pain, typhoid, tonsillitis, headache, body ache, fatigue, coryza, and viral infections. The formulation works by promoting sweat production to help lower body temperature and soothe associated pain and inflammation.
- Brand names
- Allasma
- Other names
- Allasma Tablets
Beyond the preview
Go deeper on Allasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allasma.